Pegasys

In the US, Pegasys (peginterferon alfa-2a systemic) is a member of the drug class antiviral interferons and is used to treat Hepatitis B and Hepatitis C.

US matches:

• Pegasys

UK matches:

• Pegasys 135mcg and 180mcg solution for injection in Pre-filled Syringe (SPC)

Ingredient matches for Pegasys

Peginterferon Alfa 2-a

Peginterferon Alfa 2-a is reported as an ingredient of Pegasys in the following countries:

• Algeria


• Argentina


• Armenia


• Aruba


• Australia


• Austria


• Azerbaijan


• Bahrain


• Bangladesh


• Belarus


• Belgium


• Bosnia & Herzegowina


• Brazil


• Cambodia


• Cameroon


• Canada


• Chile


• China


• Colombia


• Cote D'ivoire


• Croatia (Hrvatska)


• Cuba


• Czech Republic


• Denmark


• Dominican Republic


• Ecuador


• Egypt


• Estonia


• Finland


• France


• Georgia


• Germany


• Ghana


• Greece


• Hong Kong


• Hungary


• Iceland


• India


• Indonesia


• Iran


• Ireland


• Israel


• Italy


• Japan


• Jordan


• Kazakhstan


• Kenya


• Kuwait


• Laos


• Lebanon


• Lithuania


• Luxembourg


• Macedonia


• Malaysia


• Mauritius


• Mexico


• Morocco


• Netherlands


• New Zealand


• Norway


• Oman


• Pakistan


• Paraguay


• Peru


• Philippines


• Portugal


• Qatar


• Romania


• Russian Federation


• Saudi Arabia


• Senegal


• Serbia


• Singapore


• Slovakia


• Slovenia


• South Africa


• South Korea


• Spain


• Sri Lanka


• Sweden


• Switzerland


• Syria


• Taiwan


• Thailand


• Tunisia


• Turkey


• Ukraine


• United Arab Emirates


• United Kingdom


• United States


• Uruguay


• Uzbekistan


• Venezuela


• Vietnam

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.